Results 21 to 30 of about 46,753 (257)

Safety and efficacy of double-balloon catheter for cervical ripening: a Bayesian network meta-analysis of randomized controlled trials

open access: yesBMC Pregnancy and Childbirth, 2022
Background Various methods are used for cervical ripening during the induction of labor. Mechanical and pharmacological methods are commonly used for cervical ripening.
Ge Zhao, Guang Song, Jing Liu
doaj   +1 more source

Is Misoprostol Cost-effective in the Prevention of Nonsteroidal Anti-inflammatory Drug—Induced Gastropathy in Patients With Chronic Arthritis? [PDF]

open access: yes, 1994
Whether misoprostol, a synthetic prostaglandin E1 analogue, should be routinely prescribed along with nonsteriodal anti-inflammatory drugs (NSAIDS) to prevent gastric damage is of great clinical importance and has profound cost implications. No consensus
Johannesson, Magnus   +2 more
core   +1 more source

Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention. [PDF]

open access: yes, 2014
BackgroundBangladesh is one of the few countries that may actually achieve the fifth Millennium Development Goal (MDG) in time, despite skilled birth attendance remaining low.
Bell, Suzanne   +2 more
core   +1 more source

PERBANDINGAN EFEKTIVITAS MISOPROSTOL DOSIS 50 µg DAN 100 µg TERHADAP KEBERHASILAN KELAHIRAN INDUKSI DI RSU PKU MUHAMMADIYAH YOGYAKARTA

open access: yesPharmaciana, 2014
In recent years, misoprostol that is a prostaglandin E1 analogue has been used in cervix ripening at pregnancy and labor induction. However, until now misoprostol dosage and administration route for induction are various.
Haafizah Dania   +2 more
doaj   +1 more source

Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats.

open access: yesPLoS ONE, 2014
Nonsteroidal anti-inflammatory drugs (NSAIDs) can produce adverse effects by inhibiting prostaglandin (PG) synthesis. A PGE1 analogue, misoprostol, is often utilized to alleviate NSAID-related gastrointestinal side effects. This study examined the effect
Dustin L Cooper   +11 more
doaj   +1 more source

Hyperpyrexia After Rectal Misoprostol Administration-A Rare Side Effect of Misoprostol: Case Report

open access: yesNovelty in Biomedicine, 2022
Background: Misoprostol is a safe drug that is one of the prostaglandins analogs. It has uterotonic solid potential and is good for postpartum hemorrhage (PPH).
Masoumeh Mirzamoradi, Yekta Parsa
doaj   +1 more source

Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. [PDF]

open access: yes, 2005
OBJECTIVE: To assess the effectiveness of 600 microg oral misoprostol on postpartum haemorrhage (PPH) and postpartum anaemia in a low income country home birth situation. DESIGN: Double blind randomised controlled trial.
Blum, Jennifer   +6 more
core   +1 more source

Attenuation of ischemic liver injury by prostaglandin E1 analogue, misoprostol, and prostaglandin I2 analogue, OP-41483 [PDF]

open access: yes, 1998
Background: Prostaglandin has been reported to have protective effects against liver injury. Use of this agent in clinical settings, however, is limited because of drugrelated side effects.
Ishizaki, N   +8 more
core   +1 more source

A double-blind randomized controlled trial of two different doses of misoprostol for cervical priming prior to office hysteroscopy

open access: yesMiddle East Fertility Society Journal, 2015
Objective: To evaluate and compare the effectiveness of 200 μg vaginal misoprostol vs. 400 μg vaginal misoprostol administrated 3 h prior to office hysteroscopy, in cervical priming. Design: Randomized controlled trial.
Waleed El-Khayat   +3 more
doaj   +1 more source

Efficacy of misoprostol for the treatment of postpartum hemorrhage: current knowledge and implications for health care planning. [PDF]

open access: yes, 2016
BackgroundA myriad of interventions exist to treat postpartum hemorrhage (PPH), ranging from uterotonics and hemostatics to surgical and aortic compression devices. Nonetheless, PPH remains the leading cause of maternal mortality worldwide.
Prata, Ndola, Weidert, Karen
core   +1 more source

Home - About - Disclaimer - Privacy